Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 11, 2007, Pages 976-981

  Saibeni, Simone ^a,c   Spina, Luisa ^b   Virgilio, Tiziana ^a   Folcioni, Anna ^a,b   Borsi, Greta ^a   De Franchis, Roberto ^a   Cugno, Massimo ^a,b   Vecchi, Maurizio ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Angiotensin converting enzyme; Extraintestinal manifestations; Gene polymorphism; Inflammatory bowel disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DNA DETERMINATION; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; EYE DISEASES; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; ITALY; JOINT DISEASES; LIVER DISEASES; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SKIN DISEASES; THROMBOSIS;

EID: 37349039662     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282efa3fc     Document Type: Article

References (54)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115:182-205.
2. Kirsner JB. Genetic aspects of inflammatory bowel disease. Clin Gastroenterol 1973; 2:557-575.
3. Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005; 3:617-628.
4. Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124:1249-1264.
5. Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005; 100:886-895.
6. Stadnicki A, Gonciarz M, Niewiarowski TJ, Hartleb J, Rudnicki M, Merrell NB, et al. Activation of plasma contact and coagulation systems and neutrophils in the active phases of ulcerative colitis. Dig Dis Sci 1997; 41:1-11.
7. Devani M, Cugno M, Vecchi M, Ferrero S, Di Berardino F, Avesani EC, et al. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Am J Gastroenterol 2002; 97:2026-2032.
8. Stadnicki A, Mazurek U, Gonciarz M, Plewka D, Nowaczyk G, Orchel J, et al. Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease. Dig Dis Sci 2003; 48:615-623.
9. Devani M, Vecchi M, Ferrero S, Avesani EC, Arizzi C, Chao L, et al. Kallikrein-kinin system in inflammatory bowel diseases: intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis 2005; 37:665-673.
10. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001; 10:321-329.
11. van den Eijnden-Schrauwen Y, Kooistra T, de Vries RE, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995; 85:3510-3517.
12. Minai K, Matsumoto T, Horie H, Ohira N, Takashima H, Yokohama H, et al. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001; 37:1565-1570.
13. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68:1139-1148.
14. Miller JA, Scholey JW. The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 2004; 13:101-106.
15. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
16. Danser AHJ, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GA, et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387-1388.
17. Cody RJ. The integrated effects of angiotensin II. Am J Cardiol 1997; 79:9-11.
18. Kim DK, Kim JW, Kim S, Gwon HC, Ryu JC, Huh JE, et al. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 1997; 17:3242-3247.
19. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102:829-832.
20. Ohira N, Matsumoto T, Tamaki S, Takashima H, Tarutani Y, Yamane T, et al. Angiotensin-converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Res 2004; 27:39-45.
21. Ng DP, Tai BC, Koh D, Tan KW, Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14727 subjects. Diabetologia 2005; 48:1008-1016.
22. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94:708-712.
23. Beohar N, Prather A, Yu QT, Yu QT, Raizner A, Kleiman NS, et al. Angiotensin converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995; 43:275-280.
24. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, et al. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 2005; 162:305-317.
25. Ozturk MA, Calguneri M, Kiraz S, Ertenli I, Onat AM, Ureten K, et al. Angiotensin-converting enzyme gene polymorphism in Behcet's disease. Clin Rheumatol 2004; 23:142-146.
26. Koppel H, Renner W, Gugl A, Cichocki L, Gasser R, Wascher TC, et al. The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis. Thromb Haemost 2004; 91:76-79.
27. Jackson A, Brown K, Langdown J, Luddington R, Baglin T. Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 2000; 111:562-564.
28. Schurmann M. Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity. Am J Pharmacogenomics 2003; 3:233-243.
29. Letizia C, D'Ambrosio C, Agostini D, Corsi A, Boirivant M, Pallone F, et al. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis. Ital J Gastroenterol 1993; 25:23-25.
30. Matsuda T, Suzuki J, Furuya K, Masutani M, Kawakami Y. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis patients irrespective of genotype. Am J Gastroenterol 2001; 96:2705-2710.
31. Magro F, Dinis-Ribeiro M, Araùjo F, Pereira P, Fraga MC, Cunha-Ribeiro LM, et al. High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003; 15:1157-1163.
32. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15.
33. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42:387-391.
34. Sambrook J, Fritsch EF, Maniatis F. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbour Laboratory Press; 1989.
35. Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, et al. On behalf of the Molecular Genetic Study Group of the Italian Society of Hypertension. Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens 2003; 21:1853-1860.
36. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 2006; 367:1271-1284.
37. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
38. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004; 36:476-480.
39. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36:471-475.
40. Vermeire S, Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun 2005; 6:637-645.
41. Van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM and the Genome Scan Meta-Analysis Group of the IBD International Genetics Consortium.Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004; 13:763-770.
42. Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease. New insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44:1-13.
43. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005; 11:7227-7236.
44. Geng X, Biancone L, Dai HH, Lin JJ, Yoshizaki N, Dasgupta A, et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology 1998; 114:912-922.
45. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38:738-741.
46. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24:38-41.
47. De Vos M. Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20:36-42.
48. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112:1845-1853.
49. Papadopoulos KI, Melander O, Orho-Melander M, Groop LC, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 2000; 247:71-77.
50. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 15:33-40.
51. Suzuki Y, Ruiz-Ortega M, Gomez-Guerrero C, Tomino Y, Egido J. Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol Dial Transplant 2003; 18:1423-1426.
52. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35:881-900.
53. Diamantopoulos EJ, Andreadis EA, Vassilopoulos CV, Tabacila-Kakou MG, Sfakianakis ME, Tarassi KE, et al. Distribution of different HLA antigens in Greek hypertensives according to the angiotensin-converting enzyme genotype. Am J Hypertens 2000; 13:438-441.
54. Akcay A, Ozdemir FN, Atac FB, Sezer S, Verdi H, Arat Z, et al. Angiotensinconverting enzyme genotype is a predictive factor in the peak panel-reactive antibody response. Transplant Proc 2004; 36:35-37.